Zhonghao Pharma

中昊药业

Zhonghao Pharma

Biotech/Healthcare

Zhonghao Pharmaceutical is an innovative drug developer focused on the R&D, manufacturing, and marketing of small-molecule chemical medicines. Its core product, Benvitimod (tapinarof) cream, is a skin aryl hydrocarbon receptor (AhR) agonist used to treat inflammatory and autoimmune diseases.

Latest round: Series A (2018)

Source: ChinaBulls — chinabulls.com

Last updated 2018-03-01